Application Trends and Selection Recommendations of Tissue Microarrays (TMAs) in Precision Medicine and Biobanking

The Role of Tissue Microarrays (TMAs) in Precision Medicine Research

Precision medicine research often requires molecular typing, biomarker validation, and prognostic correlation analysis of large numbers of clinical samples. Tissue microarrays (TMAs) integrate multiple donor tissue samples into a single paraffin block, enabling in situ detection of candidate markers within a relatively short timeframe and providing a relatively consistent data foundation for cohort screening and retrospective studies. In companion diagnostic-related biomarker exploration, TMAs can serve as one of the early evaluation tools, but the final diagnostic value still needs to be determined in combination with whole-section slides and clinical trial data.

Value and Application Trends in Biobank Construction

Biobanks typically store large numbers of FFPE tissue blocks, and direct sectioning for each study accelerates sample depletion. Tissue microarrays (TMAs) can be constructed into arrays based on disease type, stage, or molecular subtype, improving sample utilization efficiency while preserving original blocks for subsequent validation. With the development of digital pathology and artificial intelligence image analysis technologies, the high-throughput nature of TMAs also facilitates the generation of standardized image datasets for model training and algorithm evaluation.

Considerations for Selecting Commercial or Custom Tissue Microarrays

When selecting commercial tissue microarrays, attention may be given to dimensions such as tissue type, core diameter, array density, number of sample cases, completeness of clinical information, and quality control reports. Common commercial arrays may cover multiple cancer types or normal tissues, suitable for initial screening and antibody performance testing; custom services allow for the selection of specific cases, specific lesion areas, and array layouts according to research design. Regardless of the format chosen, it is advisable to request TMA quality control results from suppliers to understand tissue core integrity rates, section qualification standards, and the ethical authorization status of donor samples.

Compliance and Ethical Considerations

Research involving human tissue samples should comply with relevant ethical norms and laws and regulations, ensuring donor informed consent, privacy protection, and sample use authorization. Commercial tissue microarrays (TMAs) are typically derived from ethically reviewed biobanks, and it is recommended to verify ethical approval documents or sample source documentation at the time of purchase. When research data are used for publication or product development, data security and personal information protection requirements should be observed to avoid the disclosure of identifiable individual information.

Overall, tissue microarrays (TMAs) offer notable efficiency and standardization advantages in precision medicine, biobank resource utilization, and companion diagnostic research, but reasonable selection should be made in accordance with specific research objectives, sample types, and quality control requirements.